Parker LS. The future of incidental findings: Should they be viewed as benefits? Journal of Law, Medicine & Ethics, 2008; 36(2):341-351. http://onlinelibrary.wiley.com/doi/10.1111/j.1748-720X.2008.00278.x/pdf. PMID: 18547203
Shirts BH, Parker LS. Changing interpretations, stable genes: responsibilities of patients, professionals, and policymakers in the clinical interpretation of complex genetic information. Genetics in Medicine, 2008; 10(11):778–783. doi: 10.1097/GIM.0b013e31818bb38f. PMID: 18941419
Wolf SM et al.. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genetics in Medicine, 2012; 14(4): 361-384. doi: 10.1038/gim.2012.23. PMID: 22436882
Parker LS. Returning individual research results: What role should people’s preferences play. Minnesota Journal of Law, Science & Technology, 2012; 13(2): 449-484. http://mjlst.umn.edu/prod/groups/ahc/@pub/@ahc/@mjlst/documents/content/ahc_content_396769.pdf
Parker LS. In sport and social justice, is genetic enhancement a game changer? Health Care Analysis, 2012; 20(4):328-46 doi: 10.1007/s10728-012-0226-z. PMID: 22983765
Parker LS, Satkoske VB. Ethical dimensions of disparities in depression research and treatment in the pharmacogenomic era. Journal of Law, Medicine and Ethics, 2012; 40(4): 886–903. doi: 10.1111/j.1748-720x.2012.00718.x. PMID: 23289692
Parker LS, London AJ, Aronson JD. Incidental findings in the use of DNA to identify human remains: An ethical assessment. Forensic Science International: Genetics, 2013; 7:(2): 221-229. doi: 10.1016/j.fsigen.2012.10.002. PMID: 23116722
London AJ, Parker LS, Aronson JD. DNA identification after conflict or disaster. Science, 2013; 348:1178-1179. doi: 10.1126/science.1238085. PMID: 24031004
Cohen DA, Shirts BH, Jackson BR, Parker LS. Laboratory informatics based evaluation of methylene tetrahydrofolate reductase C677T genetic test overutilization. Journal of Pathology Informatics, 2013; 4:33. doi: 10.4103/2153-3539.122389. PMID: 24392247
Dal-Ré R, Katsanis N, Katsanis S, Parker LS, Ayuso C. Managing incidental genomic findings in clinical trials: Fulfillment of the principle of justice. PLOS Medicine, 2014; 11(1): e1001584. doi: 10.1371/journal.pmed.1001584. PMID: 24453945
Grubs RE, Parker LS, Hamilton RJ. Subtle psychosocial sequelae of genetic test results. Current Genetic Medicine Reports, 2014; 2:242-249. doi: 10.1007/s40142-014-0053-7
Parker LS, Grubs RE. Ethical considerations regarding classroom use of personal genomic information. Journal of Microbiology & Biology Education, 2014; 15(2):191-196. doi: http://dx.doi.org/10.1128/jmbe.v15i2.856 PMID: 25574277
Seaman JB, Terhorst L, Gentry A, Hunsaker A, Parker LS, Lingler JH. Psychometric properties of a decisional capacity screening tool for individuals contemplating participation in Alzheimer's Disease research. Journal of Alzheimer’s Disease, 2015; 46(1):1-9. doi: 10.3233/JAD-142559. PMID: 25765917.
Ferrari R, Parker LS, Grubs RE. Sickle cell trait screening of collegiate athletes: ethical reasons for program reform. Journal of Genetic Counseling, 2015; 24(6):873-7. doi: 10.1007/s10897-015-9849-1. PMID: 26040250.
Kalynchuk EJ, Althouse A, Parker LS, Rajkovic A. Prenatal whole exome sequencing: parental attitudes. Prenatal Diagnosis, 2015; 35(10):1030-6. doi: 10.1002/pd.4635 PMID: 26151551.
Adams SM, Anderson KL, Coons JC, Smith RB, Meyer SM, Parker LS, Empey PE. Advancing pharmacogenomics education in the core PharmD curriculum through student personal genomic testing. American Journal of Pharmaceutical Education, 2016; 80(1).
Sankar PL, Parker LS. The Precision Medicine Initiative’s All of Us Research Program: an agenda for research on its ethical, legal, and social issues. Genetics in Medicine, 2017; 19(7):743-750. doi:10.1038/gim.2016.183
Pradhu A, Parker LS, DeVita M. Caring for Patients or Organs: New Therapies Raise New Dilemmas in the Emergency Department. American Journal of Bioethics (AJOB), 2017; 17(5): 6-16; doi: 10.1080/15265161.2017.1299239
Parker LS, Sankar PL, Boyer J, McEwan J, Kaufman D. Normative and Conceptual ELSI Research: What it is, and why it’s importat. Genetics in Medicine, 4 July 2018; PMID:29970926 DOI: 10.1038/s41436-018-0065-x
Herrington ER, Parker LS. Narrative methods for assessing “quality of life” in hand transplantation: five case studies with bioethical commentary. Medicine, Health Care and Philosophy, 2019; 22: 407–425; DOI: 10.1007/s11019-018-09881-4
The COVID-19 Task Force of the Association of Bioethics Program Directors (ABPD). Ethical Challenges Arising in the COVID-19 Pandemic: An Overview from the Association of Bioethics Program Directors (ABPD) Task Force. American Journal of Bioethics (AJOB), 2020, 20(7):15-27. doi: 10.1080/15265161.2020.1764138
Spector-Bagdady K et al. Flattening the Rationing Curve: The Need for Explicit Guidelines for Implicit Rationing during the COVID-19 Pandemic. American Journal of Bioethics (AJOB), 2020, 20(7): 77-80. doi: 10.1080/15265161.2020.1779409
Thomas R, Parker LS, Shiffman S. The Ethics of Tobacco Harm Reduction: An Analysis of E-Cigarette Availability From the Perspectives of Utilitarianism, Bioethics, and Public Health Ethics. Nicotine & Tobacco Research, 2021, 23(1): 3-8. doi: 10.1093/ntr/ntaa198. PMID: 33002156.
Raymond MB, Cooper KE, Parker LS, Bonham VL. Practices and Attitudes Toward Returning Genomic Research Results to Low-Resource Research Participants. Public Health Genomics, Epub 2021 Jul 6:1-12. doi: 10.1159/000516782.
Parker LS. Ethics Centers’ Conflicts of Interest and the Failure of Disclosure to Remedy this Endemic Problem. Teaching Ethics, 2022, 22(1-2):xx-xx. (Online first March 21, 2022.) https://doi.org/10.5840/tej2022321109